Beam Therapeutics Depreciation & Amortization 2011-2026 | BEAM

Annual Depreciation & Amortization Beam Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
21.9 M	20 M	14.1 M	7.45 M	4.74 M	3.5 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
21.9 M	3.5 M	12 M

Quarterly Depreciation & Amortization Beam Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
5.56 M	5.54 M	5.53 M	-	5.48 M	5.58 M	5.43 M	-	5.19 M	4.82 M	4.65 M	-	3.47 M	3.42 M	3.31 M	-	4.82 M	3.07 M	1.4 M	-	3.46 M	2.24 M	1.1 M	-	908 K	858 K	735 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.58 M	735 K	3.65 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adagene ADAG	723 K	$ 2.75	-5.5 %	$ 155 M	China
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
ANI Pharmaceuticals ANIP	67.7 M	$ 81.68	-0.39 %	$ 1.58 B	USA
Amgen AMGN	5.59 B	$ 341.02	-0.56 %	$ 183 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Aytu BioScience AYTU	5.38 M	$ 2.58	0.1 %	$ 16.2 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Biogen BIIB	673 M	$ 178.15	1.15 %	$ 25.9 B	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Arrowhead Pharmaceuticals ARWR	22.2 M	$ 70.17	1.52 %	$ 9.39 B	USA
CASI Pharmaceuticals CASI	468 K	$ 1.0	1.5 %	$ 136 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Catalyst Biosciences CBIO	1.07 M	$ 9.97	-1.77 %	$ 656 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 4.05	-1.22 %	$ 8.81 B	Israel
Amneal Pharmaceuticals AMRX	62.6 M	$ 13.87	-1.74 %	$ 4.29 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Cerus Corporation CERS	1.86 M	$ 2.34	0.65 %	$ 432 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA